Topical mupirocin versus oral erythromycin in the treatment of primary and secondary skin infections.
D000284:Administration, Oral; D000287:Administration, Topical; D001424:Bacterial Infections / Q000188:drug therapy*; D003872:Dermatitis / Q000188:drug therapy*; D004917:Erythromycin / Q000008:administration & dosage*; D005227:Fatty Acids / Q000008:administration & dosage; D006801:Humans; D016712:Mupirocin; D013203:Staphylococcal Infections / Q000188:drug therapy
D005227:Fatty Acids; D004917:Erythromycin; D016712:Mupirocin